These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26676808)

  • 1. Infliximab-induced autoantibodies: a multicenter study.
    Vaz JL; Fernandes V; Nogueira F; Arnóbio A; Levy RA
    Clin Rheumatol; 2016 Feb; 35(2):325-32. PubMed ID: 26676808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies profile of rheumatoid arthritis patients during treatment with infliximab.
    Elkayam O; Burke M; Vardinon N; Zakut V; Yitzhak RB; Paran D; Levartovsky D; Litinsky I; Caspi D
    Autoimmunity; 2005 Mar; 38(2):155-60. PubMed ID: 16040336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies in patients with psoriatic arthritis on anti-TNFα therapy.
    Viana VS; de Carvalho JF; de Moraes JC; Saad CG; Ribeiro AC; Gonçalves C; Bueno C; Vendramini MB; Bonfá E
    Rev Bras Reumatol; 2010; 50(3):225-34. PubMed ID: 21125159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of autoantibodies during prolonged treatment with infliximab.
    Louis M; Rauch J; Armstrong M; Fitzcharles MA
    J Rheumatol; 2003 Dec; 30(12):2557-62. PubMed ID: 14719194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab treatment-induced formation of autoantibodies is common in Behçet's disease.
    Elezoglou A; Kafasi N; Kaklamanis PH; Theodossiadis PG; Kapsimali V; Choremi E; Vaiopoulos G; Sfikakis PP
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S65-9. PubMed ID: 17949554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis.
    De Rycke L; Baeten D; Kruithof E; Van den Bosch F; Veys EM; De Keyser F
    Arthritis Rheum; 2005 Jul; 52(7):2192-201. PubMed ID: 15986349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of autoantibodies in refractory rheumatoid arthritis treated by infliximab.
    Allanore Y; Sellam J; Batteux F; Job Deslandre C; Weill B; Kahan A
    Clin Exp Rheumatol; 2004; 22(6):756-8. PubMed ID: 15638051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective study.
    Ferraro-Peyret C; Coury F; Tebib JG; Bienvenu J; Fabien N
    Arthritis Res Ther; 2004; 6(6):R535-43. PubMed ID: 15535831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Immunofluorescence pattern of Antinuclear Antibody with Specific Autoantibodies in the Bangladeshi Population.
    Sharmin S; Ahmed S; Abu Saleh A; Rahman F; Choudhury MR; Hassan MM
    Bangladesh Med Res Counc Bull; 2014 Aug; 40(2):74-8. PubMed ID: 26415344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity.
    Caramaschi P; Biasi D; Colombatti M; Pieropan S; Martinelli N; Carletto A; Volpe A; Pacor LM; Bambara LM
    Rheumatol Int; 2006 Jan; 26(3):209-14. PubMed ID: 15627197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha.
    Eriksson C; Engstrand S; Sundqvist KG; Rantapää-Dahlqvist S
    Ann Rheum Dis; 2005 Mar; 64(3):403-7. PubMed ID: 15297281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of antinuclear and double-strand DNA antibodies and frequency of lupus-like syndrome in anti-TNF-α antibody-treated patients with inflammatory bowel disease.
    Beigel F; Schnitzler F; Paul Laubender R; Pfennig S; Weidinger M; Göke B; Seiderer J; Ochsenkühn T; Brand S
    Inflamm Bowel Dis; 2011 Jan; 17(1):91-8. PubMed ID: 20564536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario.
    Sebastian W; Roy A; Kini U; Mullick S
    Indian J Pathol Microbiol; 2010; 53(3):427-32. PubMed ID: 20699497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of ANA specificity using multiplexed fluorescent microsphere immunoassay in patients with ANA positivity at high titres after infliximab treatment: preliminary results.
    Caramaschi P; Ruzzenente O; Pieropan S; Volpe A; Carletto A; Bambara LM; Biasi D
    Rheumatol Int; 2007 May; 27(7):649-54. PubMed ID: 17136355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-nuclear antibodies, anti-DNA and C4 complement evolution in rheumatoid arthritis and ankylosing spondylitis treated with TNF-alpha blockers.
    Gonnet-Gracia C; Barnetche T; Richez C; Blanco P; Dehais J; Schaeverbeke T
    Clin Exp Rheumatol; 2008; 26(3):401-7. PubMed ID: 18578960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The formation of autoantibodies and antibodies to TNF-α blocking agents in relation to clinical response in patients with ankylosing spondylitis.
    Arends S; Lebbink HR; Spoorenberg A; Bungener LB; Roozendaal C; van der Veer E; Houtman PM; Griep EN; Limburg PC; Kallenberg CG; Wolbink GJ; Brouwer E
    Clin Exp Rheumatol; 2010; 28(5):661-8. PubMed ID: 20822711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatment with infliximab].
    Hoxha A; Ruffatti A; Grypiotis P; Podswiadek M; Botsios C; Fiocco U; Punzi L; Todesco S
    Reumatismo; 2006; 58(2):121-6. PubMed ID: 16829990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.
    Charles PJ; Smeenk RJ; De Jong J; Feldmann M; Maini RN
    Arthritis Rheum; 2000 Nov; 43(11):2383-90. PubMed ID: 11083258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy.
    De Rycke L; Kruithof E; Van Damme N; Hoffman IE; Van den Bossche N; Van den Bosch F; Veys EM; De Keyser F
    Arthritis Rheum; 2003 Apr; 48(4):1015-23. PubMed ID: 12687543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.